← Open Payments lookup

ABLAVI AGOMESSOU: Open Payments

NPI 1164885778 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,903 in 100 payments from 15 companies in 2025. Trend: 2023 $796 · 2024 $1,593 · 2025 $1,903

Food & beverage: $1,903
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$277
Supernus Pharmaceuticals, Inc.13$273
Alkermes, Inc.10$234
Otsuka America Pharmaceutical, Inc.13$234
Teva Pharmaceuticals USA, Inc.13$200
Neurocrine BioSciences, Inc.11$199
Lundbeck LLC5$106
E.R. Squibb & Sons, L.L.C.5$105
ABBVIE INC.4$104
Corium, LLC3$44

Products named: CAPLYTA, Qelbree, ARISTADA, INGREZZA, REXULTI, ABILIFY ASIMTUFII, COBENFY, VRAYLAR.

Industry payments across GA — which companies pay providers there.